Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

PRLD

Prelude Therapeutics Incorporated

Healthcare · USD

Set alert

Price alert · PRLD

All alert types
3.88 USD -0.22 -5.37%
As of Oct 30, 2026 Extended hours 3.85 -0.77%
Bid
3.88 × 2
Ask
3.89 × 2
3.82 Day range 4.11
1.19 52-week range 6.63
YTD
+33.79%
1 year
+147.13%
Open
4.01
Prev close
4.10
Mkt cap
309.02M
Vol
218.10K
Avg vol
494.54K
EPS
-0.73
P/E
0.00
Div yield
0.00%
More statistics
Low
3.82
High
4.11
Forward P/E
-0.82
Beta
1.55
Short ratio
7.51
Inst. own
84.98%
Dividend
0.00
Ex-div date
Earnings
Aug 12, 2024
50-d avg
1.23
200-d avg
3.50
1y target
5.00

5D chart

Chart tools
Interval
1m5m15m30m
PRLD five-day price chart3.403.613.834.044.25Oct 26Oct 27Oct 28Oct 29Oct 30

Financial health

Altman Z-Score

-3.00 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 3
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 3
  • P/E 1
  • P/B 2

Valuation

P/E -2.2×
FY 2018: -2.8×FY 2019: -30.8×FY 2020: -55.0×FY 2021: -5.3×FY 2022: -2.7×FY 2023: -2.1×FY 2024: -0.8×FY 2025: -2.2×
FY 2018 5y median -2.2× FY 2025
P/S 18.4×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 13.8×FY 2025: 18.4×
FY 2018 5y median 0.0× FY 2025
P/B 3.3×
FY 2018: -1.8×FY 2019: -17.2×FY 2020: 14.7×FY 2021: 2.1×FY 2022: 1.5×FY 2023: 1.1×FY 2024: 0.7×FY 2025: 3.3×
FY 2018 5y median 1.5× FY 2025
P/FCF -4.0×
FY 2018: -3.1×FY 2019: -32.1×FY 2020: -66.8×FY 2021: -6.9×FY 2022: -3.3×FY 2023: -2.3×FY 2024: -0.9×FY 2025: -4.0×
FY 2018 5y median -3.3× FY 2025
EV/EBITDA -1.5×
FY 2018: -1.0×FY 2019: -21.5×FY 2020: -35.2×FY 2021: -3.6×FY 2022: -1.6×FY 2023: -1.5×FY 2024: -0.6×FY 2025: -1.5×
FY 2018 5y median -1.5× FY 2025
EV/Sales 11.9×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 10.8×FY 2025: 11.9×
FY 2018 5y median 0.0× FY 2025
FCF Yield -25.3%
FY 2018: -32.7%FY 2019: -3.1%FY 2020: -1.5%FY 2021: -14.5%FY 2022: -30.3%FY 2023: -42.9%FY 2024: -107.7%FY 2025: -25.3%
FY 2018 5y median -30.3% FY 2025

Profitability

Gross Margin 85.9%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 100.0%FY 2025: 85.9%
FY 2018 5y median 0.0% FY 2025
Operating Margin -861.3%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: -1995.9%FY 2025: -861.3%
FY 2018 5y median 0.0% FY 2025
Net Margin -819.6%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: -1816.8%FY 2025: -819.6%
FY 2018 5y median 0.0% FY 2025
ROE -145.0%
FY 2018: 64.7%FY 2019: 55.8%FY 2020: -26.8%FY 2021: -39.1%FY 2022: -59.1%FY 2023: -51.4%FY 2024: -96.7%FY 2025: -145.0%
FY 2018 5y median -59.1% FY 2025
ROIC -114.8%
FY 2018: -107.3%FY 2019: -162.5%FY 2020: -27.7%FY 2021: -39.5%FY 2022: -61.6%FY 2023: -51.4%FY 2024: -91.6%FY 2025: -114.8%
FY 2018 5y median -61.6% FY 2025
ROA -70.4%
FY 2018: -89.5%FY 2019: -126.1%FY 2020: -25.5%FY 2021: -36.6%FY 2022: -52.4%FY 2023: -43.9%FY 2024: -72.5%FY 2025: -70.4%
FY 2018 5y median -52.4% FY 2025

Growth (YoY)

Revenue 73.4%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 73.4%
FY 2018 FY 2025
Operating Income 25.2%
FY 2018: 0.0%FY 2019: -87.7%FY 2020: -109.1%FY 2021: -93.5%FY 2022: -8.6%FY 2023: -7.1%FY 2024: -5.6%FY 2025: 25.2%
FY 2018 FY 2025
EPS (diluted) 23.2%
FY 2018: 0.0%FY 2019: 90.9%FY 2020: -52.9%FY 2021: -79.2%FY 2022: 2.6%FY 2023: 11.0%FY 2024: 16.8%FY 2025: 23.2%
FY 2018 FY 2025
Free Cash Flow 45.6%
FY 2018: 0.0%FY 2019: -96.1%FY 2020: -77.0%FY 2021: -83.5%FY 2022: -1.0%FY 2023: -27.5%FY 2024: 6.3%FY 2025: 45.6%
FY 2018 FY 2025

Financial Health

Current Ratio 2.0×
FY 2018: 6.4×FY 2019: 4.2×FY 2020: 19.4×FY 2021: 15.4×FY 2022: 9.4×FY 2023: 10.8×FY 2024: 5.3×FY 2025: 2.0×
FY 2018 5y median 9.4× FY 2025
Quick Ratio 2.0×
FY 2018: 6.4×FY 2019: 4.2×FY 2020: 19.4×FY 2021: 15.4×FY 2022: 9.4×FY 2023: 10.8×FY 2024: 5.3×FY 2025: 2.0×
FY 2018 5y median 9.4× FY 2025
Debt / Equity 0.3×
FY 2018: 0.0×FY 2019: -0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.1×FY 2024: 0.1×FY 2025: 0.3×
FY 2018 5y median 0.1× FY 2025
Net Debt / EBITDA 0.2×
FY 2018: 1.1×FY 2019: 0.7×FY 2020: 3.7×FY 2021: 0.3×FY 2022: 0.3×FY 2023: 0.1×FY 2024: -0.0×FY 2025: 0.2×
FY 2018 5y median 0.2× FY 2025
Interest Coverage 0.0×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2018 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31